Review
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
David N. Juurlink
CMAJ April 27, 2020 192 (17) E450-E453; DOI: https://doi.org/10.1503/cmaj.200528
David N. Juurlink
Division of Clinical Pharmacology and Toxicology, Sunnybrook Health Sciences Centre; Departments of Medicine and Pediatrics, University of Toronto; ICES; Ontario Poison Centre, Toronto, Ont.
MD PhDArticle Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Respond to this article
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
David N. Juurlink
CMAJ Apr 2020, 192 (17) E450-E453; DOI: 10.1503/cmaj.200528
Jump to section
Related Articles
Cited By...
- New prophylaxis regimen for SARS-CoV-2 infection in health professionals with low doses of hydroxychloroquine and bromhexine: a randomised, double-blind placebo clinical trial (ELEVATE Trial)
- Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications
- Mental health of healthcare workers during early phase of COVID19: Variable performance on different factors of stress
- Effectiveness and Safety of Chloroquine or Hydroxychloroquine as a mono-therapy or in combination with Azithromycin in the treatment of COVID-19 patients: Systematic Review and Meta-Analysis
- Chloroquine and hydroxychloroquine effectiveness in human subjects during coronavirus: a systematic review
- Outcomes and clinical practice in patients with COVID-19 admitted to the intensive care unit in Montreal, Canada: a descriptive analysis
- Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline
- Hydroxychloroquine increased psychiatric-like behaviors and disrupted the expression of related genes in the mouse brain
- Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
- Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research
- Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection